BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24646958)

  • 21. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
    Sallinen V; Haglund C; Seppänen H
    Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors.
    Furukori M; Imai K; Karasaki H; Watanabe K; Oikawa K; Miyokawa N; Taniguchi M; Furukawa H
    World J Gastroenterol; 2014 Dec; 20(47):17949-54. PubMed ID: 25548493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors.
    Ge W; Zhou D; Xu S; Wang W; Zheng S
    Int J Surg; 2017 Mar; 39():127-134. PubMed ID: 28137555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
    Martin-Perez E; Capdevila J; Castellano D; Jimenez-Fonseca P; Salazar R; Beguiristain-Gomez A; Alonso-Orduña V; Martinez Del Prado P; Villabona-Artero C; Diaz-Perez JA; Monleon A; Marazuela M; Pachon V; Sastre-Valera J; Sevilla I; Castaño A; Garcia-Carbonero R
    Neuroendocrinology; 2013; 98(2):156-68. PubMed ID: 23988576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
    Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
    Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
    Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).
    Jung JG; Lee KT; Woo YS; Lee JK; Lee KH; Jang KT; Rhee JC
    Medicine (Baltimore); 2015 Jul; 94(26):e983. PubMed ID: 26131843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
    Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine tumors of the pancreas.
    Ehehalt F; Saeger HD; Schmidt CM; Grützmann R
    Oncologist; 2009 May; 14(5):456-67. PubMed ID: 19411317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems.
    Pomianowska E; Gladhaug IP; Grzyb K; Røsok BI; Edwin B; Bergestuen DS; Mathisen O
    Scand J Gastroenterol; 2010 Aug; 45(7-8):971-9. PubMed ID: 20441530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Ye H; Xu HL; Shen Q; Zheng Q; Chen P
    J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-functioning pancreatic endocrine tumors: eleven-year experience in a single institute.
    Fragulidis GP; Derpapas MK; Vezakis A; Melemeni A; Theodoraki K; Limouris G; Polydorou A
    J BUON; 2014; 19(2):449-52. PubMed ID: 24965405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical presentation and outcome of nonfunctional pancreatic neuroendocrine tumors in a modern cohort.
    Watley DC; Ly QP; Talmon G; Are C; Sasson AR
    Am J Surg; 2015 Dec; 210(6):1192-5; discussion 1195-6. PubMed ID: 26674063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic diagnosis and treatment of pancreatic neuroendocrine tumors.
    Rustagi T; Farrell JJ
    J Clin Gastroenterol; 2014; 48(10):837-44. PubMed ID: 24828360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
    Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
    J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
    Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
    Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution.
    Dahdaleh FS; Calva-Cerqueira D; Carr JC; Liao J; Mezhir JJ; O'Dorisio TM; Howe JR
    Ann Surg Oncol; 2012 Mar; 19(3):966-72. PubMed ID: 21845496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
    Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
    World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.